Prot# EFC3491: Van Gogh-DVT Trial, A Mltctr, Int'l, Rndmzd, Opn-Lbl, Assessor-Blind, Non-Inferiority Study Comparing Effcy & Sfty of 1x-Wkly Subcutaneous SanOrg34006 w/ Comb'n of (LMW)Heparin & Vitamin K Antagonist (VKA) in Trtm't of Acute Symptomatic Dee

Project: Research project

Project Details

StatusFinished
Effective start/end date10/17/03 → 1/1/11

Funding

  • Sanofi-Synthelabo Inc. (EFC3491/Van Gogh-DVT Trial)